| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,485 |
1,377 |
$2.10M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
18,324 |
15,524 |
$1.55M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,641 |
2,376 |
$1.33M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,417 |
5,060 |
$833K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,837 |
1,793 |
$786K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,804 |
2,676 |
$701K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,975 |
3,424 |
$675K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,844 |
2,100 |
$620K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,516 |
5,092 |
$611K |
| 0450 |
Emergency room services |
7,212 |
6,333 |
$570K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,940 |
1,800 |
$465K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
173 |
170 |
$426K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,457 |
3,729 |
$425K |
| 99199 |
Unlisted special service, procedure or report |
3,459 |
2,925 |
$422K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,493 |
8,555 |
$420K |
| 80053 |
Comprehensive metabolic panel |
21,822 |
18,921 |
$396K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,322 |
1,278 |
$385K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
11,192 |
5,926 |
$367K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,209 |
1,184 |
$359K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,686 |
3,528 |
$353K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
600 |
572 |
$351K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,716 |
1,632 |
$323K |
| 99201 |
|
2,375 |
1,998 |
$311K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,103 |
20,147 |
$281K |
| 71045 |
Radiologic examination, chest; single view |
5,633 |
5,262 |
$255K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,051 |
2,744 |
$239K |
| Q3014 |
Telehealth originating site facility fee |
6,009 |
5,312 |
$224K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,934 |
1,081 |
$202K |
| 71046 |
Radiologic examination, chest; 2 views |
3,326 |
3,174 |
$161K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,058 |
637 |
$159K |
| 82077 |
|
2,988 |
2,810 |
$152K |
| J3490 |
Unclassified drugs |
5,500 |
3,122 |
$140K |
| 97039 |
|
3,072 |
649 |
$134K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,114 |
1,083 |
$130K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
944 |
732 |
$120K |
| 84484 |
|
7,141 |
5,061 |
$113K |
| 83880 |
|
2,058 |
1,902 |
$110K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,158 |
1,105 |
$103K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,563 |
1,387 |
$102K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
452 |
443 |
$101K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
500 |
490 |
$87K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
169 |
169 |
$85K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,683 |
3,865 |
$78K |
| 0510 |
|
1,865 |
1,725 |
$75K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,780 |
4,314 |
$70K |
| 92523 |
|
955 |
413 |
$69K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
186 |
184 |
$67K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,468 |
2,394 |
$64K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
120 |
116 |
$63K |
| 71250 |
|
112 |
110 |
$58K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,081 |
1,047 |
$56K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,075 |
1,043 |
$56K |
| 87040 |
|
2,958 |
1,882 |
$54K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
740 |
638 |
$53K |
| 0270 |
|
1,510 |
757 |
$46K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
300 |
284 |
$46K |
| 83690 |
|
4,239 |
3,996 |
$45K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,353 |
3,731 |
$43K |
| 83605 |
|
2,380 |
1,808 |
$39K |
| 80061 |
Lipid panel |
2,126 |
2,073 |
$39K |
| 92134 |
|
411 |
358 |
$37K |
| 92526 |
|
393 |
216 |
$36K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,859 |
2,427 |
$35K |
| 83735 |
|
3,791 |
2,911 |
$35K |
| 85610 |
|
5,039 |
4,480 |
$33K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
38 |
37 |
$33K |
| 80143 |
|
467 |
447 |
$32K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
536 |
211 |
$32K |
| 81001 |
|
6,196 |
5,890 |
$31K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,023 |
1,984 |
$31K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,109 |
1,077 |
$30K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,663 |
2,528 |
$29K |
| 0250 |
|
942 |
632 |
$29K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,341 |
2,146 |
$27K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,023 |
975 |
$25K |
| 86481 |
|
256 |
248 |
$23K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
108 |
106 |
$23K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
12 |
12 |
$22K |
| 85730 |
|
2,472 |
2,335 |
$22K |
| 80197 |
|
1,348 |
844 |
$22K |
| 99070 |
|
1,317 |
756 |
$20K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
528 |
523 |
$20K |
| 93971 |
|
67 |
66 |
$18K |
| 80179 |
|
381 |
368 |
$18K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,731 |
1,388 |
$18K |
| 81003 |
|
3,377 |
3,222 |
$18K |
| J2704 |
Injection, propofol, 10 mg |
2,024 |
1,415 |
$17K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
124 |
114 |
$16K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
30 |
29 |
$16K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
106 |
105 |
$16K |
| 70496 |
|
32 |
32 |
$15K |
| 0760 |
|
290 |
252 |
$15K |
| 82947 |
|
1,274 |
1,094 |
$15K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
886 |
748 |
$14K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,060 |
1,005 |
$13K |
| 87186 |
|
840 |
754 |
$13K |
| 84702 |
|
1,446 |
1,363 |
$13K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
466 |
394 |
$12K |
| 86803 |
|
671 |
650 |
$12K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
40 |
40 |
$12K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
188 |
165 |
$12K |
| 81025 |
|
1,817 |
1,752 |
$12K |
| 86900 |
|
1,993 |
1,520 |
$12K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
375 |
189 |
$12K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
195 |
188 |
$11K |
| 76830 |
Ultrasound, transvaginal |
80 |
79 |
$11K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
663 |
616 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
76 |
73 |
$10K |
| 86850 |
|
1,175 |
1,085 |
$10K |
| J2060 |
Injection, lorazepam, 2 mg |
782 |
701 |
$10K |
| 96367 |
|
78 |
66 |
$9K |
| 86901 |
|
1,891 |
1,492 |
$9K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
144 |
144 |
$9K |
| 76770 |
|
100 |
99 |
$8K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
559 |
479 |
$8K |
| 85379 |
|
397 |
388 |
$8K |
| 0750 |
|
40 |
40 |
$7K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
368 |
353 |
$7K |
| 88342 |
|
235 |
229 |
$7K |
| 86140 |
|
788 |
751 |
$7K |
| 74183 |
|
12 |
12 |
$7K |
| 74174 |
|
12 |
12 |
$7K |
| 77066 |
Tomosynthesis, mammo |
26 |
26 |
$6K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
119 |
118 |
$6K |
| 82728 |
|
295 |
290 |
$6K |
| 87340 |
|
395 |
380 |
$6K |
| 70498 |
|
16 |
16 |
$6K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
988 |
880 |
$6K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
91 |
80 |
$6K |
| 86480 |
|
69 |
69 |
$5K |
| 87077 |
|
261 |
241 |
$5K |
| 97139 |
|
144 |
54 |
$5K |
| 77080 |
|
15 |
15 |
$5K |
| 82805 |
|
85 |
71 |
$5K |
| 87400 |
|
779 |
746 |
$5K |
| 84439 |
|
294 |
284 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
632 |
584 |
$4K |
| 83789 |
|
161 |
144 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
194 |
166 |
$4K |
| 86592 |
|
659 |
642 |
$4K |
| 82607 |
|
133 |
133 |
$4K |
| 73630 |
|
70 |
68 |
$4K |
| 84145 |
|
118 |
114 |
$4K |
| 87581 |
|
71 |
69 |
$4K |
| 92133 |
|
44 |
42 |
$3K |
| 87486 |
|
71 |
69 |
$3K |
| 82570 |
|
335 |
318 |
$3K |
| 88142 |
|
497 |
492 |
$3K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12 |
12 |
$3K |
| 85652 |
|
713 |
688 |
$3K |
| 83540 |
|
251 |
246 |
$3K |
| 83550 |
|
196 |
193 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
219 |
212 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
278 |
227 |
$3K |
| 0160 |
|
21 |
13 |
$3K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
285 |
211 |
$3K |
| 82043 |
|
209 |
209 |
$2K |
| 76642 |
|
15 |
15 |
$2K |
| 88341 |
|
16 |
16 |
$2K |
| 87081 |
|
380 |
374 |
$2K |
| 97750 |
|
28 |
26 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
31 |
24 |
$2K |
| 82550 |
|
212 |
199 |
$2K |
| 87420 |
|
235 |
227 |
$2K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
398 |
289 |
$2K |
| 0762 |
|
20 |
12 |
$2K |
| 93017 |
|
29 |
28 |
$2K |
| 84100 |
|
288 |
192 |
$2K |
| 86644 |
|
110 |
103 |
$2K |
| 82105 |
|
59 |
56 |
$2K |
| 82977 |
|
145 |
90 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
904 |
793 |
$1K |
| 86704 |
|
88 |
82 |
$1K |
| 84153 |
|
55 |
54 |
$1K |
| 87070 |
|
94 |
86 |
$1K |
| 87430 |
|
106 |
102 |
$1K |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
34 |
18 |
$1K |
| 86706 |
|
64 |
59 |
$1K |
| 88313 |
|
54 |
53 |
$1K |
| 92083 |
|
18 |
18 |
$807.64 |
| 86665 |
|
40 |
25 |
$774.71 |
| 83615 |
|
52 |
43 |
$613.14 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
15 |
14 |
$601.97 |
| 92250 |
|
13 |
13 |
$523.21 |
| 73562 |
|
12 |
12 |
$519.98 |
| 88312 |
|
37 |
37 |
$504.10 |
| 84550 |
|
28 |
27 |
$499.19 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
53 |
52 |
$493.84 |
| 71020 |
|
26 |
24 |
$474.97 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
12 |
12 |
$371.05 |
| 84132 |
|
43 |
41 |
$354.26 |
| 86664 |
|
27 |
25 |
$340.17 |
| 85027 |
|
52 |
49 |
$308.48 |
| 71010 |
|
20 |
19 |
$290.60 |
| 73610 |
|
13 |
12 |
$252.56 |
| 88307 |
|
13 |
12 |
$252.16 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
16 |
14 |
$247.43 |
| J7050 |
Infusion, normal saline solution, 250 cc |
44 |
29 |
$215.14 |
| 88363 |
|
14 |
14 |
$205.11 |
| 86663 |
|
13 |
13 |
$191.89 |
| J1940 |
Injection, furosemide, up to 20 mg |
14 |
13 |
$185.26 |
| 84156 |
|
38 |
37 |
$160.01 |
| 87088 |
|
12 |
12 |
$91.46 |
| 87205 |
|
14 |
13 |
$72.70 |
| 0272R |
|
16 |
12 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
15 |
12 |
$0.00 |
| 0370R |
|
16 |
12 |
$0.00 |
| 0250R |
|
16 |
12 |
$0.00 |